Oral Antibiotics Market Report by Class (Beta Lactam and Beta Lactamase Inhibitors, Quinolone, Macrolide, and Others), Application (Community-acquired Respiratory Tract Infections (CARTIs), Urinary Tract Infections (UTIs), Dental and Others), Drug Origin (Natural, Semisynthetic, Synthetic), Spectrum of Activity (Broad-spectrum Antibiotic, Narrow Spectrum Antibiotic), Drug Type (Branded, Generics), and Region 2024-2032
The global oral antibiotics market size reached US$ 20,401.4 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 27,612.2 Million by 2032, exhibiting a growth rate (CAGR) of 3.32% during 2024-2032. The increasing prevalence of infectious diseases, expanding geriatric population, escalating demand for effective treatments against drug-resistant bacteria, and the growing trend of personalized medicine and genomics represent some of the key factors driving the market.
Oral antibiotics are pharmaceutical agents primarily prescribed to inhibit bacterial growth or eliminate bacteria from the body. They are usually taken by mouth and are utilized across a wide range of medical applications. The types of infections treated by oral antibiotics vary and include common ailments such as skin, ear, throat, and urinary tract infections and more complex conditions like certain types of pneumonia. These antibiotics are categorized into different classes, each with a distinct mechanism of action. Some commonly prescribed classes include penicillins, fluoroquinolones, tetracyclines, and macrolides. Each class targets different types of bacteria and is more effective for specific bacterial infections. For instance, penicillins are widely used for streptococcal infections, while fluoroquinolones may be chosen to combat certain gram-negative bacteria. As a result, oral antibiotics are a key element of modern healthcare and are widely prescribed by healthcare professionals to enable the successful treatment of numerous bacterial infections.
Oral Antibiotics Market Trends:
The increasing prevalence of infectious diseases and the rising public awareness about the available treatment options for these conditions represent the primary factors supporting market growth. Moreover, the expanding geriatric population that is more susceptible to developing such infections is another major factor fueling the market growth. In addition, there has been a rise in antibiotic stewardship programs aimed at encouraging the widespread use of antibiotics, slowing down the emergence of antibiotic resistance, and ensuring the prolonged effectiveness of these drugs. Along with this, the growing issue of antibiotic resistance has compelled researchers and pharmaceutical companies to modify existing classes and develop new antibiotics capable of treating multi-drug resistant bacteria, thereby accelerating the product adoption rate. Furthermore, the leading pharmaceutical companies and research institutes are leveraging artificial intelligence (AI) and machine learning (ML) in the drug discovery process to predict bacterial resistance patterns, understand drug-bacteria interactions, and expedite the discovery of novel antibiotics. In line with this, the emergence of personalized medicine and genomics, which involves tailoring antibiotic treatment to individual patients by considering factors such as their genetic makeup to enhance treatment effectiveness and minimize side effects, has catalyzed market growth. Other factors, including escalating demand for effective treatments against drug-resistant bacteria, improving healthcare infrastructure, the continual launch of novel oral antibiotics, and heavy investments in research and development (R&D) activities, are also anticipated to propel the market growth in the coming years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global oral antibiotics market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on the class, application, drug origin, spectrum of activity, and drug type.
Class Insights:
Beta Lactam and Beta Lactamase Inhibitors
Penicillin
Cephalosporin
Others
Quinolone
Macrolide
Others
The report has provided a detailed breakup and analysis of the oral antibiotics market based on the class. This includes beta lactam and beta lactamase inhibitors (penicillin, cephalosporin, and others), quinolone, macrolide, and others. According to the report, beta lactam and beta lactamase inhibitors represented the largest segment.
Application Insights:
Community-acquired Respiratory Tract Infections (CARTIs)
Upper Respiratory Tract Infections (URTI)
Lower Respiratory Tract Infections (LRTIs)
Urinary Tract Infections (UTIs)
Dental
Combination
Monotherapies
Others
A detailed breakup and analysis of the oral antibiotics market based on the application has also been provided in the report. This includes community-acquired respiratory tract infections (upper respiratory tract infections (URTI) and lower respiratory tract infections (LRTIs)), urinary tract infections (UTIs), dental (combination and monotherapies), and others. According to the report, urinary tract infections (UTIs) accounted for the largest market share.
Drug Origin Insights:
Natural
Semisynthetic
Synthetic
The report has provided a detailed breakup and analysis of the oral antibiotics market based on the drug origin. This includes natural, semisynthetic, and synthetic. According to the report, synthetic represented the largest segment.
Spectrum of Activity Insights:
Broad-spectrum Antibiotic
Narrow Spectrum Antibiotic
A detailed breakup and analysis of the oral antibiotics market based on the spectrum of activity has also been provided in the report. This includes broad-spectrum antibiotic and narrow spectrum antibiotic.
Drug Type Insights:
Branded
Generics
The report has provided a detailed breakup and analysis of the oral antibiotics market based on the drug type. This includes branded and generics.
Regional Insights:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia-Pacific was the largest market for oral antibiotics. Some of the factors driving the Asia-Pacific oral antibiotics market included its aging population, growing burden of infectious diseases, high healthcare expenditure, the presence of various key players, etc.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global oral antibiotics market. Detailed profiles of all major companies have been provided. Some of the companies covered include Bayer AG, Cipla Inc., Gilead Sciences Inc., Janssen Inc. (Johnson & Johnson Services, Inc.), Pfizer Inc., Roche Holding AG, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report:
How has the global oral antibiotics market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global oral antibiotics market?
What is the impact of each driver, restraint, and opportunity on the global oral antibiotics market?
What are the key regional markets?
Which countries represent the most attractive oral antibiotics market?
What is the breakup of the market based on the class?
Which is the most attractive class in the oral antibiotics market?
What is the breakup of the market based on the application?
Which is the most attractive application in the oral antibiotics market?
What is the breakup of the market based on the drug origin?
Which is the most attractive drug origin in the oral antibiotics market?
What is the breakup of the market based on the spectrum of activity?
Which is the most attractive spectrum of activity in the oral antibiotics market?
What is the breakup of the market based on the drug type?
Which is the most attractive drug type in the oral antibiotics market?
What is the competitive structure of the global oral antibiotics market?
Who are the key players/companies in the global oral antibiotics market?
Oral antibiotics are pharmaceutical agents primarily prescribed to inhibit bacterial growth or eliminate bacteria from the body. They are usually taken by mouth and are utilized across a wide range of medical applications. The types of infections treated by oral antibiotics vary and include common ailments such as skin, ear, throat, and urinary tract infections and more complex conditions like certain types of pneumonia. These antibiotics are categorized into different classes, each with a distinct mechanism of action. Some commonly prescribed classes include penicillins, fluoroquinolones, tetracyclines, and macrolides. Each class targets different types of bacteria and is more effective for specific bacterial infections. For instance, penicillins are widely used for streptococcal infections, while fluoroquinolones may be chosen to combat certain gram-negative bacteria. As a result, oral antibiotics are a key element of modern healthcare and are widely prescribed by healthcare professionals to enable the successful treatment of numerous bacterial infections.
Oral Antibiotics Market Trends:
The increasing prevalence of infectious diseases and the rising public awareness about the available treatment options for these conditions represent the primary factors supporting market growth. Moreover, the expanding geriatric population that is more susceptible to developing such infections is another major factor fueling the market growth. In addition, there has been a rise in antibiotic stewardship programs aimed at encouraging the widespread use of antibiotics, slowing down the emergence of antibiotic resistance, and ensuring the prolonged effectiveness of these drugs. Along with this, the growing issue of antibiotic resistance has compelled researchers and pharmaceutical companies to modify existing classes and develop new antibiotics capable of treating multi-drug resistant bacteria, thereby accelerating the product adoption rate. Furthermore, the leading pharmaceutical companies and research institutes are leveraging artificial intelligence (AI) and machine learning (ML) in the drug discovery process to predict bacterial resistance patterns, understand drug-bacteria interactions, and expedite the discovery of novel antibiotics. In line with this, the emergence of personalized medicine and genomics, which involves tailoring antibiotic treatment to individual patients by considering factors such as their genetic makeup to enhance treatment effectiveness and minimize side effects, has catalyzed market growth. Other factors, including escalating demand for effective treatments against drug-resistant bacteria, improving healthcare infrastructure, the continual launch of novel oral antibiotics, and heavy investments in research and development (R&D) activities, are also anticipated to propel the market growth in the coming years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global oral antibiotics market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on the class, application, drug origin, spectrum of activity, and drug type.
Class Insights:
Beta Lactam and Beta Lactamase Inhibitors
Penicillin
Cephalosporin
Others
Quinolone
Macrolide
Others
The report has provided a detailed breakup and analysis of the oral antibiotics market based on the class. This includes beta lactam and beta lactamase inhibitors (penicillin, cephalosporin, and others), quinolone, macrolide, and others. According to the report, beta lactam and beta lactamase inhibitors represented the largest segment.
Application Insights:
Community-acquired Respiratory Tract Infections (CARTIs)
Upper Respiratory Tract Infections (URTI)
Lower Respiratory Tract Infections (LRTIs)
Urinary Tract Infections (UTIs)
Dental
Combination
Monotherapies
Others
A detailed breakup and analysis of the oral antibiotics market based on the application has also been provided in the report. This includes community-acquired respiratory tract infections (upper respiratory tract infections (URTI) and lower respiratory tract infections (LRTIs)), urinary tract infections (UTIs), dental (combination and monotherapies), and others. According to the report, urinary tract infections (UTIs) accounted for the largest market share.
Drug Origin Insights:
Natural
Semisynthetic
Synthetic
The report has provided a detailed breakup and analysis of the oral antibiotics market based on the drug origin. This includes natural, semisynthetic, and synthetic. According to the report, synthetic represented the largest segment.
Spectrum of Activity Insights:
Broad-spectrum Antibiotic
Narrow Spectrum Antibiotic
A detailed breakup and analysis of the oral antibiotics market based on the spectrum of activity has also been provided in the report. This includes broad-spectrum antibiotic and narrow spectrum antibiotic.
Drug Type Insights:
Branded
Generics
The report has provided a detailed breakup and analysis of the oral antibiotics market based on the drug type. This includes branded and generics.
Regional Insights:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia-Pacific was the largest market for oral antibiotics. Some of the factors driving the Asia-Pacific oral antibiotics market included its aging population, growing burden of infectious diseases, high healthcare expenditure, the presence of various key players, etc.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global oral antibiotics market. Detailed profiles of all major companies have been provided. Some of the companies covered include Bayer AG, Cipla Inc., Gilead Sciences Inc., Janssen Inc. (Johnson & Johnson Services, Inc.), Pfizer Inc., Roche Holding AG, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report:
How has the global oral antibiotics market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global oral antibiotics market?
What is the impact of each driver, restraint, and opportunity on the global oral antibiotics market?
What are the key regional markets?
Which countries represent the most attractive oral antibiotics market?
What is the breakup of the market based on the class?
Which is the most attractive class in the oral antibiotics market?
What is the breakup of the market based on the application?
Which is the most attractive application in the oral antibiotics market?
What is the breakup of the market based on the drug origin?
Which is the most attractive drug origin in the oral antibiotics market?
What is the breakup of the market based on the spectrum of activity?
Which is the most attractive spectrum of activity in the oral antibiotics market?
What is the breakup of the market based on the drug type?
Which is the most attractive drug type in the oral antibiotics market?
What is the competitive structure of the global oral antibiotics market?
Who are the key players/companies in the global oral antibiotics market?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL ORAL ANTIBIOTICS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY CLASS
6.1 Beta Lactam and Beta Lactamase Inhibitors
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Penicillin
6.1.2.2 Cephalosporin
6.1.2.3 Others
6.1.3 Market Forecast
6.2 Quinolone
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Macrolide
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 MARKET BREAKUP BY APPLICATION
7.1 Community-acquired Respiratory Tract Infections (CARTIs)
7.1.1 Market Trends
7.1.2 Key Segments
7.1.2.1 Upper Respiratory Tract Infections (URTI)
7.1.2.2 Lower Respiratory Tract Infections (LRTIs)
7.1.3 Market Forecast
7.2 Urinary Tract Infections (UTIs)
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Dental
7.3.1 Market Trends
7.3.2 Key Segments
7.3.2.1 Combination
7.3.2.2 Monotherapies
7.3.3 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 MARKET BREAKUP BY DRUG ORIGIN
8.1 Natural
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Semisynthetic
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Synthetic
8.3.1 Market Trends
8.3.2 Market Forecast
9 MARKET BREAKUP BY SPECTRUM OF ACTIVITY
9.1 Broad-spectrum Antibiotic
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Narrow Spectrum Antibiotic
9.2.1 Market Trends
9.2.2 Market Forecast
10 MARKET BREAKUP BY DRUG TYPE
10.1 Branded
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Generics
10.2.1 Market Trends
10.2.2 Market Forecast
11 MARKET BREAKUP BY REGION
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 DRIVERS, RESTRAINTS, AND OPPORTUNITIES
12.1 Overview
12.2 Drivers
12.3 Restraints
12.4 Opportunities
13 VALUE CHAIN ANALYSIS
14 PORTERS FIVE FORCES ANALYSIS
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 PRICE ANALYSIS
16 COMPETITIVE LANDSCAPE
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Bayer AG
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 Cipla Inc
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.2.4 SWOT Analysis
16.3.3 Gilead Sciences Inc
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.3.4 SWOT Analysis
16.3.4 Janssen Inc. (Johnson & Johnson Services, Inc)
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.5 Pfizer Inc.
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.5.4 SWOT Analysis
16.3.6 Roche Holding AG
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 Financials
16.3.7 Sun Pharmaceutical Industries Ltd
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 Financials
16.3.7.4 SWOT Analysis
16.3.8 Teva Pharmaceutical Industries Ltd.
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.8.4 SWOT Analysis
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL ORAL ANTIBIOTICS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY CLASS
6.1 Beta Lactam and Beta Lactamase Inhibitors
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Penicillin
6.1.2.2 Cephalosporin
6.1.2.3 Others
6.1.3 Market Forecast
6.2 Quinolone
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Macrolide
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 MARKET BREAKUP BY APPLICATION
7.1 Community-acquired Respiratory Tract Infections (CARTIs)
7.1.1 Market Trends
7.1.2 Key Segments
7.1.2.1 Upper Respiratory Tract Infections (URTI)
7.1.2.2 Lower Respiratory Tract Infections (LRTIs)
7.1.3 Market Forecast
7.2 Urinary Tract Infections (UTIs)
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Dental
7.3.1 Market Trends
7.3.2 Key Segments
7.3.2.1 Combination
7.3.2.2 Monotherapies
7.3.3 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 MARKET BREAKUP BY DRUG ORIGIN
8.1 Natural
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Semisynthetic
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Synthetic
8.3.1 Market Trends
8.3.2 Market Forecast
9 MARKET BREAKUP BY SPECTRUM OF ACTIVITY
9.1 Broad-spectrum Antibiotic
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Narrow Spectrum Antibiotic
9.2.1 Market Trends
9.2.2 Market Forecast
10 MARKET BREAKUP BY DRUG TYPE
10.1 Branded
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Generics
10.2.1 Market Trends
10.2.2 Market Forecast
11 MARKET BREAKUP BY REGION
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 DRIVERS, RESTRAINTS, AND OPPORTUNITIES
12.1 Overview
12.2 Drivers
12.3 Restraints
12.4 Opportunities
13 VALUE CHAIN ANALYSIS
14 PORTERS FIVE FORCES ANALYSIS
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 PRICE ANALYSIS
16 COMPETITIVE LANDSCAPE
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Bayer AG
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 Cipla Inc
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.2.4 SWOT Analysis
16.3.3 Gilead Sciences Inc
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.3.4 SWOT Analysis
16.3.4 Janssen Inc. (Johnson & Johnson Services, Inc)
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.5 Pfizer Inc.
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.5.4 SWOT Analysis
16.3.6 Roche Holding AG
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 Financials
16.3.7 Sun Pharmaceutical Industries Ltd
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 Financials
16.3.7.4 SWOT Analysis
16.3.8 Teva Pharmaceutical Industries Ltd.
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.8.4 SWOT Analysis
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
LIST OF TABLES
Table 1: Global: Oral Antibiotics Market: Key Industry Highlights, 2023 & 2032
Table 2: Global: Oral Antibiotics Market Forecast: Breakup by Class (in Million US$), 2024-2032
Table 3: Global: Oral Antibiotics Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 4: Global: Oral Antibiotics Market Forecast: Breakup by Drug Origin (in Million US$), 2024-2032
Table 5: Global: Oral Antibiotics Market Forecast: Breakup by Spectrum of Activity (in Million US$), 2024-2032
Table 6: Global: Oral Antibiotics Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
Table 7: Global: Oral Antibiotics Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 8: Global: Oral Antibiotics Market: Competitive Structure
Table 9: Global: Oral Antibiotics Market: Key Players
Table 1: Global: Oral Antibiotics Market: Key Industry Highlights, 2023 & 2032
Table 2: Global: Oral Antibiotics Market Forecast: Breakup by Class (in Million US$), 2024-2032
Table 3: Global: Oral Antibiotics Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 4: Global: Oral Antibiotics Market Forecast: Breakup by Drug Origin (in Million US$), 2024-2032
Table 5: Global: Oral Antibiotics Market Forecast: Breakup by Spectrum of Activity (in Million US$), 2024-2032
Table 6: Global: Oral Antibiotics Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
Table 7: Global: Oral Antibiotics Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 8: Global: Oral Antibiotics Market: Competitive Structure
Table 9: Global: Oral Antibiotics Market: Key Players
LIST OF FIGURES
Figure 1: Global: Oral Antibiotics Market: Major Drivers and Challenges
Figure 2: Global: Oral Antibiotics Market: Sales Value (in Million US$), 2018-2023
Figure 3: Global: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 4: Global: Oral Antibiotics Market: Breakup by Class (in %), 2023
Figure 5: Global: Oral Antibiotics Market: Breakup by Application (in %), 2023
Figure 6: Global: Oral Antibiotics Market: Breakup by Drug Origin (in %), 2023
Figure 7: Global: Oral Antibiotics Market: Breakup by Spectrum of Activity (in %), 2023
Figure 8: Global: Oral Antibiotics Market: Breakup by Drug Type (in %), 2023
Figure 9: Global: Oral Antibiotics Market: Breakup by Region (in %), 2023
Figure 10: Global: Oral Antibiotics (Beta Lactam and Beta Lactamase Inhibitors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Oral Antibiotics (Beta Lactam and Beta Lactamase Inhibitors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Oral Antibiotics (Quinolone) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Oral Antibiotics (Quinolone) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Oral Antibiotics (Macrolide) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Oral Antibiotics (Macrolide) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Oral Antibiotics (Other Classes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Oral Antibiotics (Other Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Oral Antibiotics (Community-acquired Respiratory Tract Infections (CARTIs)) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Oral Antibiotics (Community-acquired Respiratory Tract Infections (CARTIs)) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Oral Antibiotics (Urinary Tract Infections (UTIs)) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Oral Antibiotics (Urinary Tract Infections (UTIs)) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Oral Antibiotics (Dental) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Oral Antibiotics (Dental) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Oral Antibiotics (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Oral Antibiotics (Other Applications) Market Forecast: Sales Value (in Million US$), 2018-2023
Figure 26: Global: Oral Antibiotics (Natural) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Oral Antibiotics (Natural) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Oral Antibiotics (Semisynthetic) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Oral Antibiotics (Semisynthetic) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Oral Antibiotics (Synthetic) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Oral Antibiotics (Synthetic) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Global: Oral Antibiotics (Broad-spectrum Antibiotic) Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Global: Oral Antibiotics (Broad-spectrum Antibiotic) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Global: Oral Antibiotics (Narrow Spectrum Antibiotic) Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Global: Oral Antibiotics (Narrow Spectrum Antibiotic) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Global: Oral Antibiotics (Branded) Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Global: Oral Antibiotics (Branded) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Global: Oral Antibiotics (Generics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Global: Oral Antibiotics (Generics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: North America: Oral Antibiotics Market: Sales Value (in Million US$),2018 & 2023
Figure 41: North America: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: United States: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: United States: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Canada: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Canada: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Asia-Pacific: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Asia-Pacific: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: China: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: China: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Japan: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Japan: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: India: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: India: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: South Korea: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: South Korea: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Australia: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Australia: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Indonesia: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Indonesia: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Others: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Others: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Europe: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Europe: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Germany: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Germany: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: France: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: France: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: United Kingdom: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: United Kingdom: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Italy: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Italy: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Spain: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Spain: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Russia: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Russia: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Others: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Others: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Latin America: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Latin America: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 80: Brazil: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 81: Brazil: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 82: Mexico: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 83: Mexico: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 84: Others: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 85: Others: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 86: Middle East and Africa: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 87: Middle East and Africa: Oral Antibiotics Market: Breakup by Country (in %), 2023
Figure 88: Middle East and Africa: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 89: Global: Oral Antibiotics Industry: Drivers, Restraints, and Opportunities
Figure 90: Global: Oral Antibiotics Industry: Value Chain Analysis
Figure 91: Global: Oral Antibiotics Industry: Porter's Five Forces Analysis
Figure 1: Global: Oral Antibiotics Market: Major Drivers and Challenges
Figure 2: Global: Oral Antibiotics Market: Sales Value (in Million US$), 2018-2023
Figure 3: Global: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 4: Global: Oral Antibiotics Market: Breakup by Class (in %), 2023
Figure 5: Global: Oral Antibiotics Market: Breakup by Application (in %), 2023
Figure 6: Global: Oral Antibiotics Market: Breakup by Drug Origin (in %), 2023
Figure 7: Global: Oral Antibiotics Market: Breakup by Spectrum of Activity (in %), 2023
Figure 8: Global: Oral Antibiotics Market: Breakup by Drug Type (in %), 2023
Figure 9: Global: Oral Antibiotics Market: Breakup by Region (in %), 2023
Figure 10: Global: Oral Antibiotics (Beta Lactam and Beta Lactamase Inhibitors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Oral Antibiotics (Beta Lactam and Beta Lactamase Inhibitors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Oral Antibiotics (Quinolone) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Oral Antibiotics (Quinolone) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Oral Antibiotics (Macrolide) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Oral Antibiotics (Macrolide) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Oral Antibiotics (Other Classes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Oral Antibiotics (Other Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Oral Antibiotics (Community-acquired Respiratory Tract Infections (CARTIs)) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Oral Antibiotics (Community-acquired Respiratory Tract Infections (CARTIs)) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Oral Antibiotics (Urinary Tract Infections (UTIs)) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Oral Antibiotics (Urinary Tract Infections (UTIs)) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Oral Antibiotics (Dental) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Oral Antibiotics (Dental) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Oral Antibiotics (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Oral Antibiotics (Other Applications) Market Forecast: Sales Value (in Million US$), 2018-2023
Figure 26: Global: Oral Antibiotics (Natural) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Oral Antibiotics (Natural) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Oral Antibiotics (Semisynthetic) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Oral Antibiotics (Semisynthetic) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Oral Antibiotics (Synthetic) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Oral Antibiotics (Synthetic) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Global: Oral Antibiotics (Broad-spectrum Antibiotic) Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Global: Oral Antibiotics (Broad-spectrum Antibiotic) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Global: Oral Antibiotics (Narrow Spectrum Antibiotic) Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Global: Oral Antibiotics (Narrow Spectrum Antibiotic) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Global: Oral Antibiotics (Branded) Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Global: Oral Antibiotics (Branded) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Global: Oral Antibiotics (Generics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Global: Oral Antibiotics (Generics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: North America: Oral Antibiotics Market: Sales Value (in Million US$),2018 & 2023
Figure 41: North America: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: United States: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: United States: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Canada: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Canada: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Asia-Pacific: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Asia-Pacific: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: China: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: China: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Japan: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Japan: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: India: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: India: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: South Korea: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: South Korea: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Australia: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Australia: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Indonesia: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Indonesia: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Others: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Others: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Europe: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Europe: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Germany: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Germany: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: France: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: France: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: United Kingdom: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: United Kingdom: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Italy: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Italy: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Spain: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Spain: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Russia: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Russia: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Others: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Others: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Latin America: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Latin America: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 80: Brazil: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 81: Brazil: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 82: Mexico: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 83: Mexico: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 84: Others: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 85: Others: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 86: Middle East and Africa: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
Figure 87: Middle East and Africa: Oral Antibiotics Market: Breakup by Country (in %), 2023
Figure 88: Middle East and Africa: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 89: Global: Oral Antibiotics Industry: Drivers, Restraints, and Opportunities
Figure 90: Global: Oral Antibiotics Industry: Value Chain Analysis
Figure 91: Global: Oral Antibiotics Industry: Porter's Five Forces Analysis
